Skip to main content
Log in

Drug Cost Containment at a Large Teaching Hospital

  • Original Research Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

Faced with a reduction in the 1990–91 pharmaceutical budget despite escalating prices, decisive cost-saving measures had to be implemented in our 1500-bed state-funded teaching hospital. 15 drug categories were reviewed by the Medicines Control Committee in conjunction with specialist work groups based on a detailed audit of the previous year’s pharmaceutical expenditure. The usage of medicines was rationalised by paying particular attention to expensive agents, substitution of less expensive alternatives, deletion of nonessential drugs from the formulary, restriction of certain medicines and by imposing fixed budgets.

65 items were deleted from the hospital formulary. The previous trend of an increase in annual expenditure was reversed during the 1990 to 1991 financial year; for the first time, it was less than the allocated budget. The 20 Pharmaceuticals making the greatest contribution to the drug bill comprised 31% of total expenditure in the 1989 to 1990 financial year and 26% in 1990–91 and declined from R7.4 million to R5.7 million during this period, a decrease of 23%. A decrease in expenditure was realised in 14 of the 15 categories reviewed. Overall a 20% saving, or R3.3 million, was achieved for these categories.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abramowitz PM. Controlling financial variables: changing prescribing patterns. American Journal of Hospital Pharmacy 41: 503–515, 1984

    PubMed  CAS  Google Scholar 

  • Baker JA, Lant AF, Sutters CA. Seventeen years’ experience of a voluntary based drug rationalisation programme in hospital. British Medical Journal 297: 465–469, 1988

    Article  PubMed  CAS  Google Scholar 

  • Coleman RW, Rodondi LC, Kaubisch S, Granzella NB, O’Hanley PD. Cost effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. American Journal of Medicine 90: 439–444, 1991

    PubMed  CAS  Google Scholar 

  • Collier J, Foster J. Management of a restricted drugs policy in hospital: the first five years’ experience. Lancet 1(8424): 331–333, 1985

    Article  PubMed  CAS  Google Scholar 

  • Editorial. Secretary of State limits range of prescribable NHS drugs. British Medical Journal 289: 1388–1389, 1984

  • Feely J, Chan R, Cocoman L. Impact of a hospital formulary on prescribing habits and drug costs. Irish Medical Journal 80: 286–288, 1987

    PubMed  CAS  Google Scholar 

  • Feely J, Chan R, Cocoman L, Mulpeter K, O’Connor P. Hospital formularies: need for continuous intervention. British Medical Journal 300: 28–30, 1990

    Article  PubMed  CAS  Google Scholar 

  • First MR, Schroeder TJ, Alexander JW, Stephens GW, Weiskittel P, et al. Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients. Transplantation 51: 365–370, 1991

    Article  PubMed  CAS  Google Scholar 

  • First MR, Schroeder TJ, Weiskittel P, Myre SA, Alexander JW, et al. Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients. Lancet 2: 1198–1201, 1989

    Article  PubMed  CAS  Google Scholar 

  • Fowkes FGR. Doctor’s knowledge of the costs of medical care. Medical Education 19: 113–117, 1985

    Article  PubMed  CAS  Google Scholar 

  • Frazier LM, Brown JT, Divine GW, Fleming GR, Philips NM. Can physician education lower the cost of prescription drugs? Annals of Internal Medicine 115: 116–121, 1991

    PubMed  CAS  Google Scholar 

  • Gibbins FJ, Sen I, Vaz FS, Bose S. Clinical budgeting and drug management on long-stay geriatric wards. Age and Ageing 17: 328–332, 1988

    Article  PubMed  CAS  Google Scholar 

  • Harding JM, Modell M, Freudenberg S, MacGregor R, Nicolas Rea J. Prescribing: the power to set limits. British Medical Journal 290: 450–453, 1985

    Article  PubMed  CAS  Google Scholar 

  • Kim JH, Gallis H. Observation on spiraling empiricism: its causes, allure and perils, with particular reference to antibiotic therapy. American Journal of Medicine 87: 210–206, 1989

    Article  Google Scholar 

  • Louis WJ. Regulatory demands for cost benefits. American Heart Journal 119: 771–775, 1990

    Article  PubMed  CAS  Google Scholar 

  • Rowe J, Macvicar S. Doctors’ knowledge of the cost of common medications. Journal of Clinical and Hospital Pharmacy 11: 365–368, 1986

    PubMed  CAS  Google Scholar 

  • Ryan M, Yule B, Bond C, Taylor RJ. Scottish general practitioners’ attitudes and knowledge in respect of prescribing costs. British Medical Journal 300: 1316–1318, 1990

    Article  PubMed  CAS  Google Scholar 

  • Schwartz WB, Mendelson DN. Hospital cost containment in the 1980s: hard lessons learned and prospects for the 1990s. New England Journal of Medicine 324: 1037–1042, 1991

    Article  PubMed  CAS  Google Scholar 

  • Turner P. Local formularies and good patient care. British Medical Journal 288: 348, 1984

    Article  PubMed  CAS  Google Scholar 

  • Woodward RS, Medoff G, Smith MD, Gray JL. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. American Journal of Medicine 83: 817–823, 1987

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pillans, P.I., Conry, I. & Gie, B.E. Drug Cost Containment at a Large Teaching Hospital. Pharmacoeconomics 1, 377–382 (1992). https://doi.org/10.2165/00019053-199201050-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199201050-00009

Keywords

Navigation